Company intelligence / Profile preview
ImmuneRegen BioSciences
Scottsdale, Arizona, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Development-stage biotech focused on research and development of Homspera and derivatives Radilex and Viprovex; no recent clinical results reported.
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
NeoStem, Inc.University of Pittsburgh (Ted M. Ross, Ph.D.)
Beyond the preview
Go deeper on ImmuneRegen BioSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ImmuneRegen BioSciences.